| X | Filing Date | Trade Date | Ticker | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value | 1d | 1w | 1m | 6m | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-15 | RAPP | Bredt David | Chief Scientific Officer | S - Sale | $25.79 | -8,500 | 409,642 | -2% | -$219,196 | ||||||
| 2025-09-15 | RAPP | Bredt David | Chief Scientific Officer | S - Sale | $24.19 | -8,500 | 418,142 | -2% | -$205,649 | ||||||
| 2025-08-15 | RAPP | Bredt David | Chief Scientific Officer | S - Sale | $15.00 | -8,500 | 426,642 | -2% | -$127,466 | ||||||
| 2025-07-15 | RAPP | Bredt David | Chief Scientific Officer | S - Sale | $14.00 | -8,500 | 435,142 | -2% | -$118,962 | ||||||
| 2025-06-16 | RAPP | Bredt David | Chief Scientific Officer | S - Sale | $11.00 | -8,500 | 443,642 | -2% | -$93,522 | ||||||
| 2025-05-15 | RAPP | Bredt David | Chief Scientific Officer | S - Sale | $9.56 | -8,500 | 452,142 | -2% | -$81,262 | ||||||
| 2025-04-15 | RAPP | Bredt David | Chief Scientific Officer | S - Sale | $9.57 | -8,500 | 460,642 | -2% | -$81,310 | ||||||
| 2025-03-14 | RAPP | Bredt David | Chief Scientific Officer | S - Sale | $10.85 | -8,500 | 469,142 | -2% | -$92,205 | 
| A | Amended filing | 
| D | Derivative transaction in filing (usually option exercise) | 
| E | Error detected in filing | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |